Prelude Therapeutics (PRLD)
NASDAQ: PRLD
· Real-Time Price · USD
0.84
-0.10 (-11.11%)
At close: Aug 15, 2025, 3:59 PM
0.87
4.05%
After-hours: Aug 15, 2025, 04:54 PM EDT
Prelude Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7M | 7M | 6.42M | 3.42M | 3.42M | 3.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 331K | 610K | 1.33M | 2.04M | 2.51M | 3.01M | 3.03M | 3.04M | 2.93M | 2.78M | 2.52M | 2.24M | 1.55M | 931K | 442K |
Gross Profit | 7M | 7M | 6.09M | 2.81M | 2.09M | 1.38M | -2.51M | -3.01M | -3.03M | -3.04M | -2.93M | -2.78M | -2.52M | -2.24M | -1.55M | -931K | -442K |
Operating Income | -139.98M | -139.71M | -143.26M | -142.27M | -137.5M | -132.28M | -128.28M | -125.3M | -122.37M | -123.54M | -123.17M | -123.59M | -122.06M | -113.73M | -100.17M | -87.48M | -70.99M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -127.83M | -127.17M | -131.52M | -129.85M | -125.55M | -121.83M | -117.4M | -116.75M | -113.69M | -115.44M | -119.64M | -120.37M | -119.86M | -111.69M | -98.1M | -84.17M | -68.72M |
Net Income | -127.83M | -127.17M | -131.52M | -129.85M | -125.55M | -120.44M | -108.35M | -107.25M | -102.11M | -104.43M | -116.28M | -117.46M | -119.04M | -111.69M | -98.1M | -84.17M | -68.72M |
Selling & General & Admin | 27.57M | 28.72M | 29.55M | 28.76M | 28.54M | 28.88M | 29.35M | 29.75M | 30.46M | 30.65M | 30.97M | 31.57M | 28.93M | 26.96M | 24M | 18.73M | 14.88M |
Research & Development | 119.4M | 118M | 116.71M | 113.51M | 108.97M | 103.39M | 98.93M | 95.56M | 91.9M | 92.89M | 92.2M | 92.03M | 93.13M | 86.78M | 76.17M | 68.74M | 56.11M |
Other Expenses | n/a | n/a | n/a | n/a | 1.97M | 3.36M | 8.11M | 8.56M | 8.68M | 8.1M | 3.53M | 3.23M | 2.2M | 2.04M | 2.07M | 1.92M | 891K |
Operating Expenses | 146.98M | 146.71M | 146.26M | 142.27M | 137.5M | 132.28M | 128.28M | 125.3M | 122.37M | 123.54M | 123.17M | 123.59M | 122.06M | 113.73M | 100.17M | 87.48M | 70.99M |
Interest Expense | n/a | n/a | 1.4M | 1.4M | 1.4M | 1.4M | 2.91M | 2.91M | 2.91M | 2.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 146.98M | 146.71M | 146.26M | 142.27M | 137.5M | 132.28M | 128.28M | 125.3M | 122.37M | 123.54M | 123.17M | 123.59M | 122.06M | 113.73M | 100.17M | 87.48M | 70.99M |
Income Tax Expense | n/a | n/a | n/a | -279K | -39.58K | -1.44M | -9.09M | -9.26M | -11.59M | -11.01M | -3.53M | -3.08M | -991K | -168K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 75.99M | 75.9M | 75.86M | 75.76M | 75.74M | 69.59M | 67.64M | 56.24M | 47.74M | 47.9M | 47.45M | 47.28M | 47.07M | 46.33M | 46.33M | 46.06M | 45.12M |
Shares Outstanding (Diluted) | 75.99M | 75.9M | 75.86M | 75.76M | 75.74M | 69.59M | 67.64M | 56.24M | 47.74M | 47.9M | 47.45M | 47.28M | 47.07M | 46.33M | 46.33M | 46.06M | 45.12M |
EPS (Basic) | -1.69 | -1.69 | -1.79 | -1.81 | -1.89 | -2.02 | -1.98 | -2.15 | -2.14 | -2.2 | -2.47 | -2.51 | -2.56 | -2.42 | -2.22 | -2 | -1.72 |
EPS (Diluted) | -1.69 | -1.69 | -1.79 | -1.81 | -1.89 | -2.02 | -1.98 | -2.15 | -2.14 | -2.2 | -2.47 | -2.51 | -2.56 | -2.42 | -2.22 | -2 | -1.72 |
EBITDA | -138.2M | -137.94M | -141.65M | -140.78M | -136.19M | -131.11M | -127.08M | -124.05M | -121.07M | -122.22M | -121.91M | -122.41M | -120.99M | -112.82M | -99.41M | -86.84M | -70.42M |
EBIT | -139.98M | -139.71M | -143.26M | -142.27M | -137.5M | -132.28M | -128.28M | -125.3M | -122.37M | -123.54M | -123.17M | -123.59M | -122.06M | -113.73M | -100.17M | -87.48M | -70.99M |
Depreciation & Amortization | 1.78M | 1.77M | 1.61M | 1.49M | 1.76M | 2.04M | 2.51M | 3.01M | 3.03M | 3.04M | 2.93M | 2.78M | 2.52M | 2.24M | 1.69M | 1.21M | 852K |